Juan Carlos Izpisua Belmonte, Altos Labs

Not an an­ti-ag­ing play? Al­tos’ top sci­en­tist says they can pre­vent ag­ing in 20 years

The nar­ra­tive at the high­ly se­cre­tive and well-fund­ed Al­tos, brought to­geth­er by Rick Klaus­ner, is that it’s not an an­ti-ag­ing com­pa­ny. Klaus­ner made that clear when he spoke with End­points ear­li­er this year: “We do not view this as ei­ther an ag­ing com­pa­ny or a longevi­ty com­pa­ny.”

Rather, the goal was to build up a team of sci­en­tif­ic heavy­weights and top in­dus­try lead­ers, pair it with be­yond-sub­stan­tial lev­els of fund­ing with a cap­i­tal B — and then set the com­pa­ny loose in­to the depths of cel­lu­lar re­ju­ve­na­tion bi­ol­o­gy.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.